Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]Yohimbine PET Study of alpha2-adrenergic Receptors
NCT03520543Phase 1Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 11C-yohimbine (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Binding potentials at 180 minutes. Started May 2018; status: completed.
02
Drugs
11C-yohimbine
Beyond the preview
Go deeper on NCT03520543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520543.